Biotransformation is an effective method to generate new derivatives from natural products. Combination of various enzymes or whole-cell biocatalysts creates new opportunities for natural product biosynthesis. Dihydroresorcylide (1) is a phytotoxic macrolactone from Acremonium aeae. It was first chlorinated at C-11 by an engineered Escherichia coli BL21-CodonPlus (DE3)-RIL/pJZ54 strain that overexpresses a fungal flavin-dependent halogenase, and subsequently glycosylated at 12-OH by Beauveria bassiana ATCC 7159, giving rise to a novel derivative, 11-chloro-4'-O-methyl-12-O-β-D-glucosyl-dihydroresorcylide (3). Although 1 can be converted into a new 4'-O-methyl-glucosylated derivative 4 by B. bassiana, this product cannot be further chlorinated by E. coli BL21-CodonPlus (DE3)-RIL/pJZ54 to afford 3. The sequence of these two biotransformation steps was thus restricted and not interchangeable. This sequential biotransformation approach can be applied to other structurally similar natural products to create novel derivatives.
Biotransformation has been employed as an effective method to generate new derivatives from natural products. Compared to chemical synthesis, biotransformation has many advantages such as mild conditions, high regio-and stereoselectivity, and good efficiency. In our continuing efforts to biosynthesize "unnatural" natural products, we have identified some useful enzymes and whole-cell biocatalysts for structural modification. Beauveria bassiana ATCC 7159 is known to be a powerful biocatalyst that has frequently been employed in biotransformation studies due to its abundant enzyme systems, broad substrate acceptability, and its ability to perform diverse types of reactions. It has been reported that this fungus is capable of biotransformation of over 300 different substrates, involving a variety of reactions, such as hydroxylation, reduction, acetylation, glycosylation and demethylation [1] . It is such an important microbial catalyst that it is second only to Aspergillus niger as the most frequently used fungal biocatalyst [2] . Our previous studies have shown that B. bassiana can modify several structurally different substrates such as curvularin (macrolactone) and quercetin (flavonoid) to generate new glycosides [3a-3e] . This particular 4'-O-methylglucosylation is of most interest to us because the dedicated glycosyltransferase can form O-and Nglycosides from various substrates at a wide range of pH, representing a potent glycosylation biocatalyst.
Recently, we have characterized a fungal halogenase, Rdc2, from Pochonia chlamydosporia ATCC 16683 that is involved in the biosynthesis of radicicol [4a] , an antifungal and anticancer compound from filamentous fungi [4b-4e]. Unlike those previously reported halogenases, this enzyme has shown broad substrate specificity towards molecules of diverse structural characteristics and biosynthetic origin. It can accept various macrolactones such as monocillin IV, curvularin, and zearalenone as the substrates to synthesize halogenated compounds. In addition, the enzyme was also found to chlorinate curcumin, a linear plant metabolite from Curcuma longa that has a distinct structure and biosynthetic origin [4a] .
Our studies have revealed that both the glycosyltransferase from B. bassiana and Rdc2 specifically target molecules containing an aromatic ring. The similar substrate preference of these two enzymes and their remarkable broad substrate specificity make it possible to design a sequential biotransformation process for generation of novel halogenated and glycosylated compounds. Dihydroresorcylide (1, Figure 1 ) is a phytotoxic natural product from Acremonium aeae, a protective endophytic fungus of maize. In a maize leaf-puncture wound assay, 1 produced elongated lesions averaging 1.37 mm long, whereas the control (water/ methanol 1:1, v/v) exhibited only the 0.25 mm needle puncture wounds [5a] . This compound belongs to a family of macrolactones including radicicol and zearalenone that have displayed a rich array of biological activities. Since 1 has been chosen in our previous enzymatic studies on Rdc2 [4a] , we decided to continue to use this compound as the substrate to perform a sequential biotransformation. To test whether 1 can be subjected to sequential chlorination and 4'-O-methyl-glucosylation, we first prepared 11-chloro-dihdyroresorcylide (2) using the previously reported method [4a] . It has been found that Rdc2 in the original fungus is specifically inhibited by bromide at the transcriptional level, but not influenced in E. coli [5b] . Thus, reconstitution and overexpression of this fungal halogenase in a strain of E. coli will not only provide large quantity of the enzyme, but also avoid undesired inhibitory regulation by certain regulatory chemicals or proteins. A total of 61.5 mg of 1 was fed into induced broth of E. coli BL21-CodonPlus (DE3)-RIL (hereafter referred to as RIL)/pJZ54 for in vivo chlorination and 25.0 mg of 2 was purified by preparative HPLC. This compound was then used as the substrate for the glycosylation by B. bassiana to yield 5.5 mg of a new product 3 (14.3% yield).
Two [M+Na] + quasimolecular peaks at m/z 525.1 and 527.1 were found in the ratio of 3:1 in the ESIMS of 3, showing a characteristic isotope pattern for monochlorinated compounds. Accordingly, the molecular weight of 3 can be deduced to be 502, which is 176 mass units more than that of 2, suggesting that a 4'-O-methylglucose moiety has been introduced to the substrate. The 13 C and DEPT NMR spectra revealed that this new product has seven extra oxygenated carbon signals compared to 2, including one CH 3 , one CH 2 , and five CH signals, indicating that 3 is indeed a 4'-O-methyl-glucosylated product, which is further confirmed by the glucose and associated 4'-OCH 3 signals in the 1 H NMR spectrum. These signals were consistent with the previously reported NMR data for 4'-O-methyl-glucose moiety introduced by B. bassiana [3a-3e] . To determine what position the 4'-Omethyl-glucose moiety has been attached to, 2D NMR spectra were collected. As shown in Figure 2 , the HMBC spectrum has revealed the correlation of the anomeric proton (1'-H, δ 4.94) of the sugar moiety to C-12 (δ 154.4), confirming that the 4'-O-methyl-glucose moiety has been introduced to 2 at this position. Therefore, based on the spectral data, 3 can be characterized as 11-chloro-4'-Omethyl-12-O-β-D-glucosyl-dihydroresorcylide. 3 is a novel chlorinated and glycosylated derivative of the natural product 1. Thus, through a sequential biotransformation process, we were able to introduce two functionalities, chlorine atom and 4'-O-methyl-glucose, to the structure of 1 to construct a new molecule. Given the broad specificity of Rdc2 and the dedicated 4'-O-methyl-glucosyltransferase, it will be interesting to examine whether the order of the two biotransformation steps can be changed, i.e. 4'-O-methyl-glucosylation followed by chlorination. To this end, we first fed 1 into the PDB culture of B. bassiana. As expected, a new product 4 (15.0 mg, 16.4% yield) was synthesized from 57.0 mg of 1. The ESIMS spectrum of 4 revealed the quasimolecular ion peak [M+Na] + at m/z 491, indicating that the new product has a molecular weight of 468, which also has a difference of 176 mass units from that of the substrate 1. Similarly, the proton and carbon signals for a 4'-O-methyl-glucose moiety were found in the 1 H and 13 C NMR spectra of 4, confirming that 4 is formed from 4'-O-methyl-glucosylation of 1. Furthermore, the sugar moiety was determined to be linked to 12-OH by the critical HMBC correlation of the anomeric proton (1'-H, δ 4.95) to C-12 (δ 163.0) ( Figure 2 ). Thus, 4 was identified as 4'-O-methyl-12-O-β-D-glucosyl-dihydroresorcylide, which is a new derivative of 1.
Production of 4 indicated that B. bassiana can take 1 as the aglycon substrate to catalyze the expected 4'-O-methylglucosylation, further confirming that the dedicated glycosyltransferase was able to accept a wide range of substrates. Both 1 and 2 were glucosylated at the same position (C-12) with comparable yields, indicating that a chlorine atom at C-11 had no obvious effect on the selectivity and efficiency of the glycosyltransferase.
Since both Rdc2 and the dedicated glycosyltransferase were found to possess broad substrate specificity, the next question to be answered is whether the sequence of the two biotransformation steps is interchangeable. Because 1 was converted into 4 through 4'-O-methyl-glucosylation, we next tested whether 4 can be chlorinated to afford 3. To this end, 4 was incubated with the induced broth of E. coli RIL/pJZ54. However, 3 was not detected in the biotransformation broth. This revealed that the halogenase Sequential biotransformation of dihydroresorcylide Natural Product Communications Vol. 6 (2) 2011 225 cannot take 4 as the substrate to perform the 11chlorination, likely because the introduced sugar moiety interferes with the substrate-enzyme binding. Therefore, it is important to precisely arrange the reaction sequence in order to use sequential biotransformation for structural modification, which should be based on the substrate specificity of the involved enzymes.
Combinatorial or sequential biocatalysis is a useful technology for synthesizing new molecules by taking advantage of particular catalytic properties of enzymes and microbial strains [5c]. In summary, we have successfully constructed a sequential biotransformation process consisting of chlorination and 4'-O-methyl-glucosylation. Through the sequential actions of the engineered E. coli RIL/pJZ54 strain and B. bassiana, we were able to generate a novel chlorinated and glycosylated derivative of 1. Two routes (Figure 1 ) have been attempted to synthesize this new product. In route 1, 1 was first chlorinated at C-11 and then glycosylated at C-12 to give rise to 3. However, although the step of 4'-O-methyl-glucosylation of 1 in route 2 worked and yielded a new product 4, chlorination of this product into 3 was not successful. Therefore, the novel chlorinated and glycosylated derivative 3 can only be prepared through route 1 (Figure 1) . This research provides an example of preparation of novel molecules through sequential biotransformation using wide type and engineered microbial strains. Curvularin is a regioisomer of 1, with the only structural difference in the position of the lactone and ketone groups. It has been reported that this compound can be accepted as the substrate by both Rdc2 [4a] and the glycosyltransferase [3a] . Thus, it is expected that this approach can be used to generate a similar chlorinated and glycosylated derivative of curvularin. Because chlorine has been found to be a critical structural component in many bioactive natural products such as vancomycin [6] , introduction of a chlorine atom into the substrates may generate new biological activities for the derivatives. Additionally, if any of the products are found to be promising, the following glycosylation may improve the water solubility of these compounds. As many macrolactones have been found to possess promising biological activities such as antifungal and anticancer properties, our research may provide an effective tool to generate novel bioactive molecules from other macrolactones and structurally similar natural products. 
Experimental

Isolation of the substrate from A. aeae NRRL 45893:
A. aeae NRRL 45893 was grown in 30 Petri dishes, each containing 30 mL of PDA medium. After 7 days, the culture was extracted with 1 L of methanol three times. The methanol extract was concentrated under reduced pressure and separated on an Agilent 1200 HPLC using an Agilent reverse-phase Zorbax SB-C18 preparative column (21.2 x 150 mm, 5 µm). A gradient system of methanolwater was programmed 80-90% (v/v) from 0 to 10 min and 90-95% (v/v) from 10 to 20 min at a flow rate of 3 mL/min. The compound was detected at 310 nm and collected at 16.1 min. A total of 124.8 mg of 1 was purified from the extract and subsequently used as the substrate for biotransformation.
Production of 3 through sequential biotransformation:
Construction of pJZ54 by ligation of rdc2 into pET28a vector has been previously reported [4a] . The plasmid was transformed into E. coli RIL to express the halogenase. E. coli RIL/pJZ54 was grown in 8 L of LB medium supplemented with 35 µg/mL kanamycin and 25 µg/mL chloramphenicol at 37°C to an OD 600 of 0.5, which was then induced by 200 µM isopropyl-1-thio-β-D-galactoside (IPTG) at 28°C. Three hours after induction, 61.5 mg of 1 was added and the broth was maintained at 28°C and 250 rpm for an additional 36 h. After centrifugation, the supernatant was extracted with 6 L of ethyl acetate three times and the cells with 1 L of methanol. Both extracts were combined and evaporated under reduced pressure. A total of 25.0 mg of 2 was purified from the extract on HPLC using the same preparative conditions as those for 1. The retention time of 2 is 17.5 min.
B. bassiana ATCC 7159 was grown in 2 L of PDB medium at 250 rpm and 30°C for 3 days. 2 was then added into the culture and incubated under the same conditions for an additional 5 days. The biotransformation broth was then harvested by filtration. The filtrate was extracted with 2 L of ethyl acetate and mycelium with 500 mL of methanol three times. Both extracts were combined and evaporated under reduced pressure. 3 was purified using an Agilent Zorbax SB-C18 analytical column (4.6 × 150 mm, 5 µm). A gradient system of acetonitrile-water, each containing 0.1% trifluoroacetic acid (TFA), was programmed from 5 to 95% (v/v) over 30 min at a flow rate of 1 mL/min. The product was detected at 310 nm and collected at 14.8 min. A total of 5.5 mg of 3 was isolated in pure form. Its structure was determined on the basis of the spectral data. 7159 to yield 4: B. bassiana ATCC 7159 was also used to biotransform 57.0 mg of 1. The fungal strain was grown in 2 L of PDB medium under the same conditions and processed as described above. A new product 4 was purified using the Agilent Zorbax SB-C18 preparative column (21.2 x 150 mm, 5 µm). A gradient of methanol (A)-water (B) system (both containing 0.1% TFA) was programmed as below to purify 4. The flow rate was 5 mL/min and the peaks were monitored at 310 nm. 4 was collected at 10.2 min. A total of 15.0 mg of 4 was obtained in pure form. The structure of 4 was determined on the basis of the spectral data. Time (min) A% ( 
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